Post-PCI FFR in Multivessel Disease Predicts Target Vessel Failure
In a new analysis of the FAME 3 trial, post-PCI fractional flow reserve predicted both target vessel failure and the risk of cardiac events.
United States Zsolt Piroth Gottsegen Institute Of Cardiology Brown University Boston Scientific Gottsegen Institute
Source: medscape.com